Bharat Biotech, an Indian vaccine manufacturer, came out with a low dose-volume variant of its anti-diarrhoea rotavirus vaccine--Rotavac 5D recently that's expected to hamper the availability chain and delivery costs per dose. This variant is claimed to be available is little five-dose vials of 0.5 ml doses each.

The latest variant also can be stored in 2 to eight degrees C rather than of-20 degrees C that was needed for the previous one. World Health Organisation pre-qualification is awaited by the corporate for the new variant, which will make it accessible to almost 100 countries.

A syringe loaded with single-dose also will be available to the remotest small private clinics and it cost somewhere between $1 and $1.5, which is 2.5% above the previous edition, reveals company officials.

Rotavirus vaccine is an oral drop to stop diarrhoeal deaths in children. Three doses of 5 drops each need to tend to children at 6 weeks, 10 weeks and 14 weeks to guard against rotavirus infection. this is often crucial as Diarrhoea tops the chart of causes for child death under five years aged.

The company claims it's already sold 100 million doses of Rotavac in around 25 countries.